Cargando…
Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis
Long non-coding RNA H19 (H19) is highly expressed in cancers and is considered to highly correlate with the extent of malignant degree. The present study was performed to determine the expression levels of H19 in anaplastic thyroid carcinoma (ATC) tissues and the role of H19 in ATC 8505C cells in vi...
Autores principales: | Zhang, Honglai, Yu, Ying, Zhang, Kejun, Liu, Xinfeng, Dai, Yan, Jiao, Xuelong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650201/ https://www.ncbi.nlm.nih.gov/pubmed/31299871 http://dx.doi.org/10.1080/21655979.2019.1642722 |
Ejemplares similares
-
The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
por: Song, Hao, et al.
Publicado: (2018) -
Retracted: The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
por: Song, Hao, et al.
Publicado: (2022) -
Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways
por: Li, Tingting, et al.
Publicado: (2019) -
Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer
por: Saini, Shikha, et al.
Publicado: (2019) -
Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis
por: Sadowski, Samira M., et al.
Publicado: (2015)